No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs10900291 |
chr10:43474694-43474695 |
Enhancers Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
2 |
rs573788405 |
chr10:43474746-43474747 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs76000027 |
chr10:43474788-43474789 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs559242760 |
chr10:43474791-43474792 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs533083684 |
chr10:43474874-43474875 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs544884443 |
chr10:43474947-43474948 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs563751231 |
chr10:43474954-43474955 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs530767960 |
chr10:43474958-43474959 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs573366864 |
chr10:43474985-43474986 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs549468372 |
chr10:43475013-43475014 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs528948314 |
chr10:43475032-43475033 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs567621711 |
chr10:43475040-43475041 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs528718622 |
chr10:43475042-43475043 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs73262104 |
chr10:43475059-43475060 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
15 |
rs142150090 |
chr10:43475061-43475062 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs184810390 |
chr10:43475062-43475063 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs557366671 |
chr10:43475087-43475088 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs548810756 |
chr10:43475115-43475116 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs536601181 |
chr10:43475143-43475144 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs190208165 |
chr10:43475152-43475153 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs151222091 |
chr10:43475165-43475166 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs192340017 |
chr10:43475208-43475209 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs552781152 |
chr10:43475209-43475210 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs577415744 |
chr10:43475267-43475268 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs184834064 |
chr10:43475274-43475275 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs544908429 |
chr10:43475275-43475276 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs531360286 |
chr10:43475281-43475282 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs189607619 |
chr10:43475306-43475307 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs78190284 |
chr10:43475383-43475384 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs2488279 |
chr10:43475416-43475417 |
Enhancers Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
31 |
rs542628523 |
chr10:43475480-43475481 |
Enhancers Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs73262106 |
chr10:43475483-43475484 |
Enhancers Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
33 |
rs528631982 |
chr10:43475490-43475491 |
Enhancers Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs181976677 |
chr10:43475505-43475506 |
Enhancers Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs375517706 |
chr10:43475516-43475517 |
Enhancers Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs1541225 |
chr10:43475568-43475569 |
Enhancers Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
37 |
rs532704843 |
chr10:43475601-43475602 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs551264343 |
chr10:43475610-43475611 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs56677915 |
chr10:43475648-43475649 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
40 |
rs537070170 |
chr10:43475649-43475650 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs58032110 |
chr10:43475651-43475652 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
42 |
rs79164303 |
chr10:43475653-43475654 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs534449284 |
chr10:43475679-43475680 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs41295811 |
chr10:43475699-43475700 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
45 |
rs41295813 |
chr10:43475719-43475720 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
46 |
rs141393534 |
chr10:43475750-43475751 |
Weak transcription Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs557246060 |
chr10:43475757-43475758 |
Weak transcription Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs532703856 |
chr10:43475759-43475760 |
Weak transcription Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs11239851 |
chr10:43475778-43475779 |
Weak transcription Enhancers
|
lncRNA
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
50 |
rs185980665 |
chr10:43475791-43475792 |
Weak transcription Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|